Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
24 July, 2017 04:12 IST
Jubilant Life' arm to negotiate potential acquisition of speciality biz in USA
Source: IRIS | 21 Mar, 2017, 10.16AM
Comments  |  Post Comment

Jubilant Life Sciences' material wholly owned subsidiary in Singapore, Jubilant Pharma (JPL) has received an approval to negotiate a potential acquisition of a speciality pharma business in the United States using only internal accruals, subject to due diligence, satisfactory agreements, etc. and its final approval. The board of directors of JPL at its meeting has approved for the same.

The proposed acquisition is a niche, profitable speciality pharma business with a strategic fit and is expected to provide competitive edge for JPL's existing business, if it materializes.

Shares of the company gained Rs 7.65, or 0.97%, to trade at Rs 793.00. The total volume of shares traded was 81,616 at the BSE (10.08 a.m., Tuesday).



Jubilant Life Sciences Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer